SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-00-000008
Filing Date
2000-05-15
Accepted
2000-05-15 00:00:00
Documents
8
Period of Report
2000-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 78134
2 EXHIBIT 2.3 EX-2.3 143041
3 EXHIBIT 10.219 EX-10.219 105458
4 EXHIBIT 10.220 EX-10.220 119238
5 EXHIBIT 10.221 EX-10.221 11769
6 EXHIBIT 10.222 EX-10.222 13328
7 EXHIBIT 10.223 EX-10.223 147333
8 EXHIBIT 27.1 EX-27.1 2791
  Complete submission text file 0000886163-00-000008.txt   623160
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20720 | Film No.: 635112
SIC: 2834 Pharmaceutical Preparations